{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T07:25:33Z","timestamp":1775201133036,"version":"3.50.1"},"reference-count":45,"publisher":"Pharmaceutical Society of Japan","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2021,2,1]]},"DOI":"10.1248\/bpb.b20-00510","type":"journal-article","created":{"date-parts":[[2021,1,31]],"date-time":"2021-01-31T22:07:13Z","timestamp":1612130833000},"page":"181-187","source":"Crossref","is-referenced-by-count":8,"title":["Transient Receptor Potential Melastatin 3 Is Functionally Expressed in Oligodendrocyte Precursor Cells and Is Upregulated in Ischemic Demyelinated Lesions"],"prefix":"10.1248","volume":"44","author":[{"given":"Kana","family":"Ohashi","sequence":"first","affiliation":[{"name":"Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Shibasaki","sequence":"additional","affiliation":[{"name":"Division of Neurochemistry, Graduate School of Human Health Science, University of Nagasaki"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayaki","family":"Nakazawa","sequence":"additional","affiliation":[{"name":"Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryotaro","family":"Kunimasa","sequence":"additional","affiliation":[{"name":"Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Nagayasu","sequence":"additional","affiliation":[{"name":"Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Shirakawa","sequence":"additional","affiliation":[{"name":"Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Dimou L, Gallo V. NG2-glia and their functions in the central nervous system. <i>Glia<\/i>, <b>63<\/b>, 1429\u20131451 (2015).","DOI":"10.1002\/glia.22859"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Iijima K, Kurachi M, Shibasaki K, Naruse M, Puentes S, Imai H, Yoshimoto Y, Mikuni M, Ishizaki Y. Transplanted microvascular endothelial cells promote oligodendrocyte precursor cell survival in ischemic demyelinating lesions. <i>J. Neurochem.<\/i>, <b>135<\/b>, 539\u2013550 (2015).","DOI":"10.1111\/jnc.13262"},{"key":"3","unstructured":"3) Xu S, Lu J, Shao A, Zhang JH, Zhang J. Glial cells: role of the immune response in ischemic stroke. <i>Front. Immunol.<\/i>, <b>11<\/b>, 294 (2020)."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Sypecka J, Sarnowska A. The neuroprotective effect exerted by oligodendroglial progenitors on ischemically impaired hippocampal cells. <i>Mol. Neurobiol.<\/i>, <b>49<\/b>, 685\u2013701 (2014).","DOI":"10.1007\/s12035-013-8549-9"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Seo JH, Miyamoto N, Hayakawa K, Pham LD, Maki T, Ayata C, Kim KW, Lo EH, Arai K. Oligodendrocyte precursors induce early blood\u2013brain barrier opening after white matter injury. <i>J. Clin. Invest.<\/i>, <b>123<\/b>, 782\u2013786 (2013).","DOI":"10.1172\/JCI65863"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Harlow DE, Saul KE, Komuro H, Macklin WB. Myelin proteolipid protein complexes with \u03b1v integrin and AMPA receptors <i>in vivo<\/i> and regulates AMPA-dependent oligodendrocyte progenitor cell migration through the modulation of cell-surface GluR2 expression. <i>J. Neurosci.<\/i>, <b>35<\/b>, 12018\u201312032 (2015).","DOI":"10.1523\/JNEUROSCI.5151-14.2015"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Kougioumtzidou E, Shimizu T, Hamilton NB, Tohyama K, Sprengel R, Monyer H, Attwell D, Richardson WD. Signalling through AMPA receptors on oligodendrocyte precursors promotes myelination by enhancing oligodendrocyte survival. <i>eLife<\/i>, <b>6<\/b>, e28080 (2017).","DOI":"10.7554\/eLife.28080"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Santiago Gonz\u00e1lez DA, Cheli VT, Zamora NN, Lama TN, Spreuer V, Murphy GG, Paez PM. Conditional deletion of the L-type calcium channel cav1.2 in NG2-positive cells impairs remyelination in mice. <i>J. Neurosci.<\/i>, <b>37<\/b>, 10038\u201310051 (2017).","DOI":"10.1523\/JNEUROSCI.1787-17.2017"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Pitman KA, Ricci R, Gasperini R, Beasley S, Pavez M, Charlesworth J, Foa L, Young KM. The voltage-gated calcium channel CaV1.2 promotes adult oligodendrocyte progenitor cell survival in the mouse corpus callosum but not motor cortex. <i>Glia<\/i>, <b>68<\/b>, 376\u2013392 (2020).","DOI":"10.1002\/glia.23723"},{"key":"10","unstructured":"10) Thiel G, Rubil S, Lesch A, Guethlein LA, R\u00f6ssler OG. Transient receptor potential TRPM3 channels: Pharmacology, signaling, and biological functions. <i>Pharmacol. Res.<\/i>, <b>124<\/b>, 92\u201399 (2017)."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Paez PM, Fulton D, Spreuer V, Handley V, Campagnoni AT. Modulation of canonical transient receptor potential channel 1 in the proliferation of oligodendrocyte precursor cells by the golli products of the myelin basic protein gene. <i>J. Neurosci.<\/i>, <b>31<\/b>, 3625\u20133637 (2011).","DOI":"10.1523\/JNEUROSCI.4424-10.2011"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Ohashi K, Deyashiki A, Miyake T, Nagayasu K, Shibasaki K, Shirakawa H, Kaneko S. TRPV4 is functionally expressed in oligodendrocyte precursor cells and increases their proliferation. <i>Pflugers Arch.<\/i>, <b>470<\/b>, 705\u2013716 (2018).","DOI":"10.1007\/s00424-018-2130-3"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Papanikolaou M, Lewis A, Butt AM. Store-operated calcium entry is essential for glial calcium signalling in CNS white matter. <i>Brain Struct. Funct.<\/i>, <b>222<\/b>, 2993\u20133005 (2017).","DOI":"10.1007\/s00429-017-1380-8"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Hoffmann A, Grimm C, Kraft R, Goldbaum O, Wrede A, Nolte C, Hanisch UK, Richter-Landsberg C, Br\u00fcck W, Kettenmann H, Harteneck C. TRPM3 is expressed in sphingosine-responsive myelinating oligodendrocytes. <i>J. Neurochem.<\/i>, <b>114<\/b>, 654\u2013665 (2010).","DOI":"10.1111\/j.1471-4159.2010.06644.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Wagner TF, Loch S, Lambert S, Straub I, Mannebach S, Mathar I, D\u00fcfer M, Lis A, Flockerzi V, Philipp SE, Oberwinkler J. Transient receptor potential M3 channels are ionotropic steroid receptors in pancreatic \u03b2 cells. <i>Nat. Cell Biol.<\/i>, <b>10<\/b>, 1421\u20131430 (2008).","DOI":"10.1038\/ncb1801"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Grimm C, Kraft R, Schultz G, Harteneck C. Activation of the melastatin-related cation channel TRPM3 by D-<i>erythro<\/i>-sphingosine. <i>Mol. Pharmacol.<\/i>, <b>67<\/b>, 798\u2013805 (2005).","DOI":"10.1124\/mol.104.006734"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Grimm C, Kraft R, Sauerbruch S, Schultz G, Harteneck C. Molecular and functional characterization of the melastatin-related cation channel TRPM3. <i>J. Biol. Chem.<\/i>, <b>278<\/b>, 21493\u201321501 (2003).","DOI":"10.1074\/jbc.M300945200"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Son A, Kang N, Kang JY, Kim KW, Yang YM, Shin DM. TRPM3\/TRPV4 regulates Ca<sup>2+<\/sup>-mediated RANKL\/NFATc1 expression in osteoblasts. <i>J. Mol. Endocrinol.<\/i>, <b>61<\/b>, 207\u2013218 (2018).","DOI":"10.1530\/JME-18-0051"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Vriens J, Owsianik G, Hofmann T, Philipp SE, Stab J, Chen X, Benoit M, Xue F, Janssens A, Kerselaers S, Oberwinkler J, Vennekens R, Gudermann T, Nilius B, Voets T. TRPM3 is a nociceptor channel involved in the detection of noxious heat. <i>Neuron<\/i>, <b>70<\/b>, 482\u2013494 (2011).","DOI":"10.1016\/j.neuron.2011.02.051"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Held K, Voets T, Vriens J. TRPM3 in temperature sensing and beyond. <i>Temperature <\/i>(Austin), <b>2<\/b>, 201\u2013213 (2015).","DOI":"10.4161\/23328940.2014.988524"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Fonfria E, Murdock PR, Cusdin FS, Benham CD, Kelsell RE, McNulty S. Tissue distribution profiles of the human TRPM cation channel family. <i>J. Recept. Signal Transduct. Res.<\/i>, <b>26<\/b>, 159\u2013178 (2006).","DOI":"10.1080\/10799890600637506"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Zamudio-Bulcock PA, Valenzuela CF. Pregnenolone sulfate increases glutamate release at neonatal climbing fiber-to-Purkinje cell synapses. <i>Neuroscience<\/i>, <b>175<\/b>, 24\u201336 (2011).","DOI":"10.1016\/j.neuroscience.2010.11.063"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Zamudio-Bulcock PA, Everett J, Harteneck C, Valenzuela CF. Activation of steroid-sensitive TRPM3 channels potentiates glutamatergic transmission at cerebellar Purkinje neurons from developing rats. <i>J. Neurochem.<\/i>, <b>119<\/b>, 474\u2013485 (2011).","DOI":"10.1111\/j.1471-4159.2011.07441.x"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Shirakawa H, Katsumoto R, Iida S, Miyake T, Higuchi T, Nagashima T, Nagayasu K, Nakagawa T, Kaneko S. Sphingosine-1-phosphate induces Ca<sup>2+<\/sup> signaling and CXCL1 release <i>via<\/i> TRPC6 channel in astrocytes. <i>Glia<\/i>, <b>65<\/b>, 1005\u20131016 (2017).","DOI":"10.1002\/glia.23141"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Puentes S, Kurachi M, Shibasaki K, Naruse M, Yoshimoto Y, Mikuni M, Imai H, Ishizaki Y. Brain microvascular endothelial cell transplantation ameliorates ischemic white matter damage. <i>Brain Res.<\/i>, <b>1469<\/b>, 43\u201353 (2012).","DOI":"10.1016\/j.brainres.2012.06.042"},{"key":"26","unstructured":"26) Sheehan D, Hrapchak B. <i>Theory and practice of histotechnology<\/i>, second ed., The CV Mosby Company, St. Louis, pp. 235\u2013237 (1980)."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Ma J, Matsumoto M, Tanaka KF, Takebayashi H, Ikenaka K. An animal model for late onset chronic demyelination disease caused by failed terminal differentiation of oligodendrocytes. <i>Neuron Glia Biol.<\/i>, <b>2<\/b>, 81\u201391 (2006).","DOI":"10.1017\/S1740925X06000056"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Straub I, Kr\u00fcgel U, Mohr F, Teichert J, Rizun O, Konrad M, Oberwinkler J, Schaefer M. Flavanones that selectively inhibit TRPM3 attenuate thermal nociception <i>in vivo.<\/i> <i>Mol. Pharmacol.<\/i>, <b>84<\/b>, 736\u2013750 (2013).","DOI":"10.1124\/mol.113.086843"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Hayakawa K, Pham LD, Som AT, Lee BJ, Guo S, Lo EH, Arai K. Vascular endothelial growth factor regulates the migration of oligodendrocyte precursor cells. <i>J. Neurosci.<\/i>, <b>31<\/b>, 10666\u201310670 (2011).","DOI":"10.1523\/JNEUROSCI.1944-11.2011"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Tokumoto Y, Tamaki S, Kabe Y, Takubo K, Suematsu M. Quiescence of adult oligodendrocyte precursor cells requires thyroid hormone and hypoxia to activate Runx1. <i>Sci. Rep.<\/i>, <b>7<\/b>, 1019 (2017).","DOI":"10.1038\/s41598-017-01023-9"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Meletti S, Lucchi C, Monti G, Giovannini G, Bedin R, Trenti T, Rustichelli C, Biagini G. Decreased allopregnanolone levels in cerebrospinal fluid obtained during status epilepticus. <i>Epilepsia<\/i>, <b>58<\/b>, e16\u2013e20 (2017).","DOI":"10.1111\/epi.13625"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Nilius B, Voets T. A TRP channel-steroid marriage. <i>Nat. Cell Biol.<\/i>, <b>10<\/b>, 1383\u20131384 (2008).","DOI":"10.1038\/ncb1208-1383"},{"key":"33","unstructured":"33) Bi\u010d\u00edkov\u00e1 M, Tallov\u00e1 J, Hill M, Krausov\u00e1 Z, Hampl R. Serum concentrations of some neuroactive steroids in women suffering from mixed anxiety-depressive disorder. <i>Neurochem. Res.<\/i>, <b>25<\/b>, 1623\u20131627 (2000)."},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Tagawa N, Takano T, Fukata S, Kuma K, Tada H, Izumi Y, Kobayashi Y, Amino N. Serum dehydroepiandrosterone, dehydroepiandrosterone sulfate, and pregnenolone sulfate concentrations in patients with hyperthyroidism and hypothyroidism. <i>Clin. Chem.<\/i>, <b>46<\/b>, 523\u2013528 (2000).","DOI":"10.1093\/clinchem\/46.4.523"},{"key":"35","unstructured":"35) Schumacher M, Liere P, Akwa Y, Rajkowski K, Griffiths W, Bodin K, Sj\u00f6vall J, Baulieu EE. Pregnenolone sulfate in the brain: a controversial neurosteroid. <i>Neurochem. Int.<\/i>, <b>52<\/b>, 522\u2013540 (2008)."},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Zwain IH, Yen SS. Neurosteroidogenesis in astrocytes, oligodendrocytes, and neurons of cerebral cortex of rat brain. <i>Endocrinology<\/i>, <b>140<\/b>, 3843\u20133852 (1999).","DOI":"10.1210\/endo.140.8.6907"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Salman ED, Faye-Petersen O, Falany CN. Hydroxysteroid sulfotransferase 2B1b expression and localization in normal human brain. <i>Horm. Mol. Biol. Clin. Investig.<\/i>, <b>8<\/b>, 445\u2013454 (2011).","DOI":"10.1515\/HMBCI.2011.117"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Chudakova DA, Zeidan YH, Wheeler BW, Yu J, Novgorodov SA, Kindy MS, Hannun YA, Gudz TI. Integrin-associated Lyn kinase promotes cell survival by suppressing acid sphingomyelinase activity. <i>J. Biol. Chem.<\/i>, <b>283<\/b>, 28806\u201328816 (2008).","DOI":"10.1074\/jbc.M803301200"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Badheka D, Yudin Y, Borbiro I, Hartle CM, Yazici A, Mirshahi T, Rohacs T. Inhibition of transient receptor potential melastatin 3 ion channels by G-protein \u03b2\u03b3 subunits. <i>eLife<\/i>, <b>6<\/b>, e26147 (2017).","DOI":"10.7554\/eLife.26147"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Quallo T, Alkhatib O, Gentry C, Andersson DA, Bevan S. G protein \u03b2\u03b3 subunits inhibit TRPM3 ion channels in sensory neurons. <i>eLife<\/i>, <b>6<\/b>, e26138 (2017).","DOI":"10.7554\/eLife.26138"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Shimauchi-Ohtaki H, Kurachi M, Naruse M, Shibasaki K, Sugio S, Matsumoto K, Ema M, Yoshimoto Y, Ishizaki Y. The dynamics of revascularization after white matter infarction monitored in Flt1-tdsRed and Flk1-GFP mice. <i>Neurosci. Lett.<\/i>, <b>692<\/b>, 70\u201376 (2019).","DOI":"10.1016\/j.neulet.2018.10.057"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Kimura I, Dohgu S, Takata F, Matsumoto J, Watanabe T, Iwao T, Yamauchi A, Kataoka Y. Oligodendrocytes upregulate blood\u2013brain barrier function through mechanisms other than the PDGF-BB\/PDGFR\u03b1 pathway in the barrier-tightening effect of oligodendrocyte progenitor cells. <i>Neurosci. Lett.<\/i>, <b>715<\/b>, 134594 (2020).","DOI":"10.1016\/j.neulet.2019.134594"},{"key":"43","unstructured":"43) Ono H, Imai H, Miyawaki S, Nakatomi H, Saito N. Rat white matter injury model induced by endothelin-1 injection: technical modification and pathological evaluation. Acta. <i>Neurobiol. Exp.<\/i> (Wars), <b>76<\/b>, 212\u2013224 (2016)."},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Kirby L, Jin J, Cardona JG, Smith MD, Martin KA, Wang J, Strasburger H, Herbst L, Alexis M, Karnell J, Davidson T, Dutta R, Goverman J, Bergles D, Calabresi PA. Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination. <i>Nat. Commun.<\/i>, <b>10<\/b>, 3887 (2019).","DOI":"10.1038\/s41467-019-11638-3"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Evonuk KS, Doyle RE, Moseley CE, Thornell IM, Adler K, Bingaman AM, Bevensee MO, Weaver CT, Min B, DeSilva TM. Reduction of AMPA receptor activity on mature oligodendrocytes attenuates loss of myelinated axons in autoimmune neuroinflammation. <i>Sci. Adv.<\/i>, <b>6<\/b>, eaax5936 (2020).","DOI":"10.1126\/sciadv.aax5936"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/44\/2\/44_b20-00510\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T04:33:04Z","timestamp":1612585984000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/44\/2\/44_b20-00510\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,1]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b20-00510","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,1]]}}}